Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen
AI heavyweight Anthropic has appointed Novartis CEO Vas Narasimhan to its board of directors as the link between…
Novartis pens $1.7B atopic disease pact with British biotech
Novartis has tapped up an artificial-intelligence-enabled British biotech for a $1.7 billion biobucks deal to discover new targets…
Novartis finds natural partnership in macrocycle biotech
Unnatural Products is proving to be a natural at securing partnerships, this time linking up with Novartis in…
Roche inks Nvidia expansion to bolster AI factory
Swiss pharma Roche is staying in lockstep with Eli Lilly, expanding its artificial intelligence offerings and Nvidia partnership…